$BMRA
BIOMERICA INC
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
$2.32
▼-2.11%-$0.050
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBIOMERICA INC
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
Why is BMRA down today? It is at $2.32 (-2.11%), and our scanner flagged it 4 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BMRA spikes, and full due diligence on BMRA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BMRA 4 times in the last 30 days. Create a free account to track $BMRA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BMRA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BMRA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Irani Zackary S. Officer | Bought (open market) | +31K 0.7% of company | added 15% | 243K | $50K at $1.60 | Aug 26, 26 |
Barbieri Allen Officer | Bought (open market) | +20K 0.4% of company | added 37% | 74K | $32K at $1.60 | Aug 26, 26 |
Chin Eric Director | Bought (open market) | +6K 0.1% of company | added 19% | 39K | $10K at $1.60 | Aug 26, 26 |
Moatazedi David Director | Bought (open market) | +10K 0.2% of company | added 33% | 41K | $16K at $1.60 | Aug 26, 26 |
Gary M. Huff Director | Bought (open market) | +31K 0.7% of company | added 100% | 51K | $50K at $1.60 | Aug 20, 26 |
Irani Zackary S. Officer | Acquired (grant/award) | +53K 1.1% of company | added 33% | 211K | n/a | Dec 12, 25 |
Gary M. Huff Director | Acquired (grant/award) | +20K 0.4% of company | n/a | 20K | n/a | Dec 12, 25 |
Barbieri Allen Officer | Acquired (grant/award) | +30K 0.7% of company | added 100% | 54K | n/a | Dec 12, 25 |
Lu Gary Officer | Acquired (grant/award) | +40K 0.9% of company | added 100% | 59K | n/a | Dec 12, 25 |
Moatazedi David Director | Acquired (grant/award) | +20K 0.4% of company | added 100% | 31K | n/a | Dec 12, 25 |
Chin Eric Director | Acquired (grant/award) | +23K 0.5% of company | added 100% | 33K | n/a | Dec 12, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
Here is the latest on BMRA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BMRA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BMRA last traded at $2.32, down 2.11% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
BIOMERICA INC (BMRA) is next expected to report earnings on Tuesday, October 13, 2026, about 26 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BMRA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BMRA 4 times in the last 30 days.
BMRA (BIOMERICA INC) trades on XNAS, with a market cap of about $11M in the In Vitro & In Vivo Diagnostic Substances sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BMRA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BMRA discussion
Sign in to ask a question or join the discussion.